Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells

Editing Process, Immunology, Primary Cells | January 23, 2025 | By Paolo Piazza, Daniel Orozco, John Latimer
Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells
Share

Interested in how EditCo can reliably edit T cells without affecting function? Check out our on-demand webinar.

Learn More
Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision
Editing Process

Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision

Delivering high-quality, precisely edited cells requires more than just cutting-edge CRISPR technology—it begins with a strong foundation in cell culture. Meet Argo: The Backbone of EditCo’s Automated Cell Culture Named after the legendary ship that carried Jason and the Argonauts, Argo represents our modern-day vessel for scientific exploration. Housed in a sterile enclosure, Argo is the backbone of our cell culture operations, built for high-throughput expansion, refeeding, and imaging of both immortalized and induced pluripotent stem (iPS) cells . Figure 1. Photo of the Argo workcell.

Read More
CRISPR Confidence: The Power of Controls in Genome Editing
CRISPR Screening

CRISPR Confidence: The Power of Controls in Genome Editing

Key Takeaways CRISPR controls are essential for optimizing editing efficiency, validating phenotypes, and improving experimental reproducibility. Positive, negative, AAVS1, and lethal controls each serve distinct purposes throughout CRISPR workflows. CRISPR controls are widely used in functional genomics, pooled and arrayed screening, stem cell engineering, and drug discovery. EditCo provides validated CRISPR control reagents compatible with immortalized, primary, and iPSC models. Common CRISPR Control Types and Their Applications CRISPR genome editing is transforming biological research, and experimental controls are the backbone of reliable, reproducible results. In this article, we explore the essential role of CRISPR controls and supporting reagents in optimizing editing efficiency, troubleshooting workflows, and ensuring consistency across experiments. Whether you’re editing immortalized cells , iPSCs , or primary cells , CRISPR positive and negative controls are key to unlocking the full potential of your gene editing experiments. Why CRISPR Controls Matter CRISPR controls are not just “nice to have” — they are fundamental to every step of a genome editing experiment: Optimization: Use controls to fine-tune transfection parameters and editing protocols across different cell types and workflows. Controls help establish optimal conditions before investing in gene-specific reagents. Assay Development : Optimize transfection conditions and editing performance before targeting your gene of interest. Screening and Validation : Confirm editing efficiency and distinguish true biological effects from technical artifacts. Troubleshooting : Identify potential problems with delivery, reagent performance, or cell health. Without appropriate controls, even the most promising CRISPR screen can yield ambiguous or misleading results.

Read More
CRISPR-Edited Fibroblasts: Applications in Disease Modeling, Cancer Research, and Drug Discovery
Disease Models

CRISPR-Edited Fibroblasts: Applications in Disease Modeling, Cancer Research, and Drug Discovery

Key Takeaways Fibroblasts are central to fibrosis, wound healing, and the tumor microenvironment. CRISPR enables precise functional studies in primary fibroblasts. Cancer-associated fibroblasts (CAFs) are becoming major therapeutic targets. High-throughput CRISPR screening is accelerating fibroblast research. Scalable engineered fibroblast models improve reproducibility in drug discovery. Fibroblasts are essential connective tissue cells that play a key role in extracellular matrix production, wound healing, and cellular signaling. In more recent years, fibroblasts have been implicated in oncologic malignancies, specifically the tumor microenvironment or TME (the ecosystem surrounding a tumor composed of various cells, ECM, and soluble factors). However, this cell type remains significantly understudied and is the focus of many researchers across academia, biotechs, and pharmaceutical companies.

Read More